These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Characterization of novel cell lines established from three human oral squamous cell carcinomas. Lee G; Kim YB; Kim JH; Kim MS; Shin KH; Won YS; Lee JI; Choung PH; Hyun BH; Min BM Int J Oncol; 2002 Jun; 20(6):1151-9. PubMed ID: 12011992 [TBL] [Abstract][Full Text] [Related]
64. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation. Yamada H; Yoshida T; Sakamoto H; Terada M; Sugimura T Biochem Biophys Res Commun; 1986 Oct; 140(1):167-73. PubMed ID: 3778442 [TBL] [Abstract][Full Text] [Related]
65. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas. Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770 [TBL] [Abstract][Full Text] [Related]
66. Amplification of the c-myc proto-oncogene in cervical carcinoma. Baker VV; Hatch KD; Shingleton HM J Surg Oncol; 1988 Dec; 39(4):225-8. PubMed ID: 3193767 [TBL] [Abstract][Full Text] [Related]
67. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation. Sugerman PB; Joseph BK; Savage NW Oral Dis; 1995 Sep; 1(3):172-88. PubMed ID: 8705824 [TBL] [Abstract][Full Text] [Related]
68. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726 [TBL] [Abstract][Full Text] [Related]
69. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785 [TBL] [Abstract][Full Text] [Related]
70. Cancer genes alterations and HPV infection in oral squamous cell carcinoma. Popović B; Jekić B; Novaković I; Luković L; Konstantinović V; Babić M; Milasin J Int J Oral Maxillofac Surg; 2010 Sep; 39(9):909-15. PubMed ID: 20579853 [TBL] [Abstract][Full Text] [Related]
72. Amplification of the c-myc proto-oncogene in human chondrosarcoma. Castresana JS; Barrios C; Gómez L; Kreicbergs A Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971 [TBL] [Abstract][Full Text] [Related]
73. Ras oncogenes in oral cancer: the past 20 years. Murugan AK; Munirajan AK; Tsuchida N Oral Oncol; 2012 May; 48(5):383-92. PubMed ID: 22240207 [TBL] [Abstract][Full Text] [Related]
74. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene. Vilette D; Emanoil-Ravier R; Tobaly J; Peries J Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619 [TBL] [Abstract][Full Text] [Related]
75. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000 [TBL] [Abstract][Full Text] [Related]
76. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
77. A transforming Kirsten ras oncogene in an oral squamous carcinoma. Howell RE; Wong FS; Fenwick RG J Oral Pathol Med; 1990 Aug; 19(7):301-5. PubMed ID: 2231435 [TBL] [Abstract][Full Text] [Related]
78. Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas. Saint-Ruf C; Gerbault-Seureau M; Viegas-Péquignot E; Zafrani B; Cassingena R; Dutrillaux B Genes Chromosomes Cancer; 1990 May; 2(1):18-26. PubMed ID: 2177639 [TBL] [Abstract][Full Text] [Related]
79. [Oncogenes in squamous epithelial cancers in the area of the head and neck]. Volling P; Jungehülsing M; Tesch H; Stennert E Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367 [TBL] [Abstract][Full Text] [Related]
80. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients. Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Deo MG Br J Cancer; 1990 Apr; 61(4):530-3. PubMed ID: 1970484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]